Biogen Idec Inc $345.84

up +1.24


19/8/2014 04:00 PM  |  NASDAQ : BIIB  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get BIIB Trend Analysis - it has outperformed the S&P 500 by 47%

Partner Headlines

  1. Biogen's buy rating reaffirmed

    IBD
  2. UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Plegridy Approval

    Benzinga
  3. Perrigo Regains Some Lost Ground On Fiscal Q4 Beat

    IBD
  4. Perrigo Q4 Beats Estimates, But Guidance Misses

    IBD
  5. Tech, Health Care Lead Q2 Earnings Beats

    IBD
  6. #PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq

    Benzinga
  7. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  8. Why Investors Should Closely Watch Celgene

    Benzinga
  9. Biotech Gets A Lift On Popular Drug, Strong Pipeline

    IBD
  10. Ken Fisher's Top Increaes of the Second Quarter

    GuruFocus
  11. Ken Fisher's Top Increases of the Second Quarter

    GuruFocus
  12. Chipotle, Facebook Rally On Upside Earnings Surprise

    IBD
  13. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  14. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  15. Biogen, Gilead Profits Soar

    IBD
  16. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  17. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  18. IPO Stock Watch: Biotechs Are Half Of July Calendar

    IBD
  19. Vertex Is Poised For An Earnings Breakout

    Benzinga
  20. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout ...

    Benzinga
  21. S&P 500 Flirts With High; Breadth Missing On Nasdaq

    IBD
  22. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  23. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  24. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  25. Apple, Microsoft Lead Nasdaq Higher; Dow Falters

    IBD
  26. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  27. Stocks: Mixed Open, Mixed Trade; Delta, Broadcom, Biogen Buck Up

    IBD
  28. Morning Market Movers

    Benzinga
  29. UPDATE: Biogen Idec Posts Stronger-Than-Expected Q2 Results, Shares Surge

    Benzinga
  30. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  31. Benzinga's Top #PreMarket Gainers

    Benzinga
  32. Earnings Scheduled For July 23, 2014

    Benzinga
  33. Stocks Rise; Apple, Microsoft Steady In Post-Session

    IBD
  34. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  35. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  36. Oil Dominates; Keurig, Constellation Near Buy Points

    IBD
  37. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  38. Biogen Shares Rebound As Street Has A Change Of Heart

    IBD
  39. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  40. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  41. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  42. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  43. IBD Big Cap 20 Leaders Hold Up Well Despite Shaky Market

    IBD
  44. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  45. Stocks Close Higher As Biotech, Internet Stocks Gain

    IBD
  46. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly

    Benzinga
  47. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  48. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  49. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  50. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
Trading Center